Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
04/1999
04/22/1999CA2305698A1 Human progesterone receptor complex p23-like protein
04/22/1999CA2305643A1 Murine model for human carcinoma
04/21/1999EP0909564A1 Erythropoietin solution preparation
04/21/1999EP0633261B1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof
04/21/1999CN1214252A Sphinx extract oral liquid
04/20/1999US5895783 Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
04/20/1999CA2250664A1 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
04/15/1999WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive
04/15/1999WO1999017770A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity
04/15/1999WO1999000422A9 Novel family of pheromone receptors
04/15/1999DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals
04/15/1999CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive
04/15/1999CA2306245A1 Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy
04/15/1999CA2304466A1 Indeno[1,2-c]pyrazole derivatives for inhibiting tyrosine kinase activity
04/14/1999EP0907652A1 Immunosuppressive compounds and methods
04/14/1999EP0907643A1 Compounds with growth hormone releasing properties
04/14/1999EP0907366A1 Combination therapy for treatment of erectile dysfunction
04/14/1999EP0748221B1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
04/14/1999CN1213967A Benzothiophenes, formulations containing same, and methods
04/14/1999CN1042933C Benzoylguanidine, prepn. of same and application as pharmaceutical and pharmaceutical containing same
04/08/1999WO1999016881A1 Antigen protein and nucleic acid coding for said protein
04/08/1999WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
04/08/1999WO1999016453A1 Method for the treatment of cystic fibrosis
04/08/1999WO1999016440A1 Amorphous paroxetine composition
04/08/1999WO1999016312A1 Method for treating sexual dysfunction
04/08/1999CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
04/08/1999CA2304594A1 Amorphous paroxetine composition
04/08/1999CA2304482A1 Method for the treatment of cystic fibrosis
04/08/1999CA2304472A1 Method for treating sexual dysfunction
04/07/1999EP0906959A2 Aminopeptidase from Staphylococcus aureus
04/07/1999EP0906761A2 Method of preparing and using phytochemicals
04/07/1999EP0906127A1 Novel devices for transdermal administering of trimegestone
04/07/1999EP0906105A1 Improvement of implantation rates after in vitro fertilization
04/07/1999EP0781268B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
04/07/1999EP0632033B1 Novel benzopyran derivative
04/07/1999CN1212871A Health-care beverage and its manufacture method
04/06/1999US5892039 Piperazino derivatives as neurokinin antagonists
04/06/1999US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen
04/06/1999US5891867 Hormonal medicaments and their use for the correction of oestrogenic deficiencies
04/06/1999US5891840 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis
04/06/1999US5891457 Treating menorrhagia with silver nitrate composition
04/06/1999US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use
04/01/1999WO1999015521A1 Benzothiophenes
04/01/1999WO1999015165A1 Topical non-steroidal anti-inflammatory drug composition
04/01/1999WO1999015016A1 Methods for regulating trka expression
04/01/1999CA2304191A1 Topical non-steroidal anti-inflammatory drug composition
04/01/1999CA2304138A1 Benzothiophenes
04/01/1999CA2304114A1 Methods for regulating trka expression
03/1999
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905142A1 Inhibitors against prostate-specific antigen
03/31/1999EP0905132A1 Benzothiophenes
03/31/1999EP0904294A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904089A1 Methods for sterilizing female mammals
03/31/1999EP0904087A1 Phosphatidic acid-comprising compositions
03/31/1999EP0904084A1 Emergency contraceptive kit
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0660711B1 Novel use of inhibitors of phosphodiestersase iv
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889145 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889042 Method of treating diseases and conditions with estrogen agonists and antagonists
03/30/1999US5889036 Prophylactic or therapeutic drug for renal diseases
03/30/1999US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
03/30/1999US5888986 Method for treating the urinary bladder and associated structures using hyaluronic acid
03/30/1999US5888964 Method for increasing placental blood flow
03/30/1999US5888812 Myeloid cell leukemia associated gene MCL-1
03/30/1999US5888534 Controlled release of drugs delivered by sublingual or buccal administration
03/30/1999US5888523 Topical non-steroidal anti-inflammatory drug composition
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999013897A1 Prevention of pregnancy miscarriages
03/25/1999WO1999013883A1 Androgen as a male contraceptive and non-contraceptive androgen replacement
03/25/1999WO1999013882A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
03/25/1999WO1999013862A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
03/25/1999WO1999013812A1 Transdermal administration of ment
03/25/1999WO1999013717A1 A delivery of arginine to cause beneficial effects
03/25/1999WO1999001109A3 Therapeutical system for transdermal delivery of levonorgestrel
03/25/1999WO1998050067A9 Use or a secretion vector for fertility control by oral vaccination
03/25/1999CA2469084A1 Androgen as a male contraceptive and non-contraceptive androgen replacement
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304205A1 Prevention of pregnancy miscarriages
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2301162A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999CN1211991A Compounds with growth hormone releasing properties
03/24/1999CN1211436A Medicine for preventing and curing bleeding side reaction after abortion by drug
03/23/1999US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999CA2130878C 4-aminopyrimidine derivatives
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/23/1999CA1340455C Human preproinsulin-like growth factor i
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012536A1 Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 557